Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine Company Limited, also known as Jiangsu Hengrui Medicine, is a Chinese pharmaceutical company which engaged in the research, development, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics.[1] It is also the largest listed pharmaceutical company in China.[2]
listed company | |
Traded as | SSE: 600276 |
Founded | 1997 |
Headquarters | Lianyungang, Jiangsu |
Area served | China |
Key people | Sun Piaoyang (chairman) |
Website | www |
The company was established in 1997 and headquartered in Lianyungang, Jiangsu. It was listed on Shanghai Stock Exchange in 2000.[3]
References
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.